Myasthenia gravis: open trials in United Kingdom

10 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT06055959
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · UCB Biopharma SRL
Mg0014 40735, Glasgow · Mg0014 40736, London
Registry updated 2026-11-05
NCT05374590
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Great Ormand Street Hospital for Children NHS Foundation Trust - Great Ormond Street Hospital - Pediatric Neurology, London · Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital Children's Hospital, Oxford
Registry updated 2026-11-03
NCT06987539
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Trial Treatment · Phase 2 · Amgen
John Radcliffe Hospital, Oxford
Registry updated 2026-10-23
NCT06463587
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Trial Treatment · Phase 3 · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Queen Square Centre for Neuromuscular Diseases, London · Nottingham University Hospitals NHS Trust, Nottingham · Royal Hallamshire Hospital - Dept of Neurology, Sheffield
Registry updated 2026-10-21
NCT06435312
An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Mg0015 40735, Glasgow · Mg0015 40736, London
Registry updated 2026-10-02
NCT06392386
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Oxford Children's Hospital, Oxford
Registry updated 2026-09-28
NCT07039916
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Trial Treatment · Phase 3 · Immunovant Sciences GmbH
Birmingham · Glasgow · London
Registry updated 2026-07-30
NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · Kyverna Therapeutics
Cambridge University Hospital, Addenbrooke's Hospital, Cambridge · King's College Hospital, London
Registry updated 2026-07-29
NCT06312644
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Research · Alexion Pharmaceuticals, Inc.
London
Registry updated 2026-04-16
NCT06064461
Vitaccess Real MG Registry
Research · Vitaccess Ltd
University Hospitals Birmingham, Birmingham · Vitaccess Ltd, London
Registry updated 2025-07-29

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error